Prophages and growth dynamics confound experimental results with antibiotic-tolerant persister cells by Harms, Alexander et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Prophages and growth dynamics confound experimental results with antibiotic-
tolerant persister cells
Harms, Alexander; Fino, Cinzia; Sørensen, Michael Askvad; Semsey, Szabolcs; Gerdes,
Kenn
Published in:
mBio
DOI:
10.1128/mBio.01964-17
Publication date:
2017
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Harms, A., Fino, C., Sørensen, M. A., Semsey, S., & Gerdes, K. (2017). Prophages and growth dynamics
confound experimental results with antibiotic-tolerant persister cells. mBio, 8(6), [e01964-17].
https://doi.org/10.1128/mBio.01964-17
Download date: 03. Feb. 2020
Prophages and Growth Dynamics
Confound Experimental Results with
Antibiotic-Tolerant Persister Cells
Alexander Harms, Cinzia Fino, Michael A. Sørensen, Szabolcs Semsey,
Kenn Gerdes
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Copenhagen, Copenhagen, Denmark
ABSTRACT Bacterial persisters are phenotypic variants that survive antibiotic treat-
ment in a dormant state and can be formed by multiple pathways. We recently pro-
posed that the second messenger (p)ppGpp drives Escherichia coli persister forma-
tion through protease Lon and activation of toxin-antitoxin (TA) modules. This
model found considerable support among researchers studying persisters but also
generated controversy as part of recent debates in the ﬁeld. In this study, we there-
fore used our previous work as a model to critically examine common experimental
procedures to understand and overcome the inconsistencies often observed be-
tween results of different laboratories. Our results show that seemingly simple anti-
biotic killing assays are very sensitive to variations in culture conditions and bacterial
growth phase. Additionally, we found that some assay conditions cause the killing of
antibiotic-tolerant persisters via induction of cryptic prophages. Similarly, the inad-
vertent infection of mutant strains with bacteriophage 80, a notorious laboratory
contaminant, apparently caused several of the phenotypes that we reported in our
previous studies. We therefore reconstructed all infected mutants and probed the
validity of our model of persister formation in a reﬁned assay setup that uses robust
culture conditions and unravels the dynamics of persister cells through all bacterial
growth stages. Our results conﬁrm the importance of (p)ppGpp and Lon but no lon-
ger support a role of TA modules in E. coli persister formation under unstressed con-
ditions. We anticipate that the results and approaches reported in our study will lay
the ground for future work in the ﬁeld.
IMPORTANCE The recalcitrance of antibiotic-tolerant persister cells is thought to
cause relapsing infections and antibiotic treatment failure in various clinical set-
ups. Previous studies identiﬁed multiple genetic pathways involved in persister
formation but also revealed reproducibility problems that sparked controversies
about adequate tools to study persister cells. In this study, we unraveled how
typical antibiotic killing assays often fail to capture the biology of persisters and
instead give widely differing results based on poorly controlled experimental pa-
rameters and artifacts caused by cryptic as well as contaminant prophages. We
therefore established a new, robust assay that enabled us to follow the dynamics
of persister cells through all growth stages of bacterial cultures without distor-
tions by bacteriophages. This system also favored adequate comparisons of mu-
tant strains with aberrant growth phenotypes. We anticipate that our results will
contribute to a robust, common basis for future studies on the formation and
eradication of antibiotic-tolerant persisters.
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Bacterial persisters constitute a subpopulation of phenotypically antibiotic-tolerantcells that form within a population of genetically antibiotic-susceptible bacteria.
Persister cells are usually slowly growing or nongrowing, and researchers in the ﬁeld
largely agree that the antibiotic tolerance of persisters is linked to a dormant physio-
logical state in which the cellular processes commonly poisoned by bactericidal anti-
biotics are inactive (1, 2). Consistently, a large body of studies from several laboratories
has uncovered genetic pathways that control and execute the formation of persister
cells of Escherichia coli K-12 as a phenotypic conversion into dormancy (1, 2). These
mechanisms include a drop of cellular ATP levels, the modulation of nucleoid-
associated proteins, changes in metabolic ﬂuxes, high expression of drug efﬂux pumps,
or the activation of different sets of toxin-antitoxin (TA) modules (3–10). The emerging
picture is therefore that various parallel and partially interlinked pathways of persister
formation in E. coli K-12 give rise to a heterogeneous population of persisters that have
formed through different pathways, have different physiological properties, and thus
exhibit different proﬁles of antibiotic tolerance (1, 2, 11).
The complexity of bacterial persister formation and the sensitivity of persistence
assays to even slight experimental variation have generated controversies that have
made the ﬁeld notorious for debates on the technical and biological aspects of
studying bacterial persistence (12–16). Among the work cited above, our laboratory has
published a series of studies linking persister formation in E. coli K-12 to the activation
of a set of 10 mRNA endonuclease toxin TA modules under control of the second
messenger (p)ppGpp, polyphosphate, and protease Lon (8, 9). Though similar ﬁndings
have been made, e.g., in Salmonella enterica serovar Typhimurium (17), our model has
also been met with skepticism by other researchers in the ﬁeld (5, 13, 14, 18). In the
present study, we therefore carefully reevaluated our previous conclusions as well as
the underlying methodology and also probed common experimental procedures for
sources of the frequently observed inconsistencies between studies in the ﬁeld.
In short, we discovered that E. coli mutant strains used in our previous work had
been inadvertently infected with several different lysogenic bacteriophages and that
prophage carriage strongly affected persistence measurements. However, we also show
that already the resident cryptic prophages of the E. coli K-12 MG1655 wild-type strain
distort the results of persister assays under conditions that are commonly used in the
ﬁeld. Importantly, we show that the common practice of determining persister levels at
only a single growth time point is often inappropriate to account for shifted dynamics
of growth and persister formation in mutant strains. We ﬁnally tested the key compo-
nents of our previously proposed model of persister formation using new mutant
strains and a reﬁned methodology. Crucially, we could conﬁrm a role of (p)ppGpp,
polyphosphate, and Lon in bacterial persister formation and/or survival but did not ﬁnd
strong evidence for the involvement of TA modules or the connection of these
components in a single pathway of persister formation under unstressed conditions.
RESULTS
Classical persister assays suffer from technical and biological drawbacks. The
formation of persister cells is typically measured by determining the fraction of
antibiotic-tolerant cells in bacterial cultures that are considered to be exponentially
growing some hours after inoculation from dense overnight cultures (Fig. 1A). A
biphasic kinetic of antibiotic killing reveals the presence of persister cells, because these
are killed slowly and can be detected after the regular cells have been rapidly
eliminated in a ﬁrst phase of killing (19). Despite the apparent simplicity of this
experimental setup, persister assays are known to be sensitive to even minor variations
of the experimental conditions and have often given inconsistent results in different
laboratories (5, 16, 20, 21). We therefore suspected that this simple assay setup may be
inadequate to represent the dynamic nature of bacterial persistence and could give
results that are strongly affected by biological or technical parameters that are usually
not controlled in persistence assays.
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As a ﬁrst step toward understanding the notorious variability of results reported for
single-growth-time-point persister assays, we followed the absolute levels of colony form-
ing units (CFUs) and antibiotic-tolerant cells over time from inoculation of an E. coli culture
through exponential growth into stationary phase in Luria-Bertani (LB) medium (Fig. 1B and
C). Cultures were treated with lethal concentrations of ampicillin, ciproﬂoxacin, or genta-
micin (representing -lactams, ﬂuoroquinolones, and aminoglycosides that kill by very
different mechanisms) for 5 h that are more than sufﬁcient to kill all regular cells at least
during exponential growth so that only persisters remain (5, 8, 9, 11).
Most importantly, we found that cultures inoculated with different numbers of cells
from overnight cultures displayed systematically different fractions of antibiotic-
tolerant cells at any given total CFU count per milliliter during exponential growth (e.g.,
at ca. 5  108 CFU/ml reached after 2, 3, and 4 h of growth under conditions of
inoculation at 1:100, 1:1,000, and 1:10,000 dilutions from stationary-phase overnight
cultures, respectively; Fig. 1B and C). As an example, the fraction of cells tolerant to
FIG 1 Persister assays are affected by inoculum and growth phase. (A) Scheme illustrating the setup of a persister assay as it is commonly
performed in the ﬁeld. (B) Cultures of E. coli K-12 MG1655 were grown in LB medium after inoculation at a dilution of 1:100 (blue), 1:1,000
(orange), or 1:10,000 (green) from dense overnight cultures, and levels of all CFUs as well as levels of antibiotic-tolerant CFUs were
determined at each time point. (C) Fraction of antibiotic-tolerant cells for each data point reported as described for panel B. Data points
are shown for one representative experiment, because the absolute numbers of antibiotic-tolerant cells (but not their dynamics) were
affected considerably by batch-to-batch variations of the LB medium (see Fig. S1). n.d., not detected (no gentamicin-tolerant bacteria
recovered at t  0 h from inoculation at a dilution of 1:10,000).
Prophages and Culture Conditions Affect Persister Assays ®
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1 g/ml of ciproﬂoxacin, a commonly used treatment setup, was 104, 105, or 106
at this growth stage (5 108 CFU/ml) depending on the inoculum. Similar ﬁndings had
already been published previously by Balaban et al. (22) but were not widely taken into
account for the design and interpretation of antibiotic killing assays. Importantly, these
observations are incompatible with the idea that this setup of persister assays is
measuring stochastic persister formation of exponentially growing bacteria, since this
should be independent of the inoculum. Furthermore, the levels of tolerant cells
differed massively between the three antibiotics and over time even during periods
when the overall CFU per milliliter changed only marginally, highlighting that the
heterogeneity of persister cells makes it inappropriate to simply report “persister levels”
from a single time point or a given cell density.
In addition, we observed variations of results obtained with different batches of LB
medium in a manner in which bacterial growth and the overall dynamics of antibiotic
tolerance were not affected but in which the absolute levels of tolerant cells varied
considerably (see Fig. S1 in the supplemental material). It is well known that LB medium
is prone to batch-to-batch variation that essentially cannot be controlled in the
laboratory, e.g., due to the degradation of L-tryptophan over time depending on the
exposure to ambient light or the degree of L-asparagine and L-glutamine deamidation
during autoclaving (23). Furthermore, the poor content of divalent cations and sugars
in LB medium causes variations in the availability of these important nutrients to E. coli
cultures due to even minor differences in handling during the preparation of each
batch (24).
Following the dynamics of E. coli persister cells in M9 medium. To overcome the
issues outlined above, we decided to switch the culture medium from LB to the more
deﬁned M9 medium (see details in Materials and Methods) and adopted the determi-
nation of antibiotic tolerance in bacterial cultures over time as our standard procedure
(Fig. 2A). Studying the dynamics of E. coli K-12 wild-type cells tolerant to ampicillin,
ciproﬂoxacin, or gentamicin as described above, the results of experimental replicates
were much more homogeneous and showed similarities to but also differences from
those obtained in previous experiments performed in LB medium (Fig. 2B and C). For
ampicillin, the level of tolerant cells remained constant after inoculation throughout
exponential growth and then sharply increased during late-exponential growth until all
bacteria were ampicillin-tolerant in stationary phase, because this antibiotic is unable to
kill nongrowing cells (25). Similarly, the number of ciproﬂoxacin-tolerant cells was
stable for the ﬁrst hours and then increased into stationary phase, while—unlike the
results seen with ampicillin—only up to 10% of the population became tolerant. For
gentamicin, the dynamics of antibiotic-tolerant cells looked very different from those
seen with the other antibiotics, and the levels of tolerant cells initially increased until
mid-exponential phase, decreased again until entry into stationary phase, and ﬁnally
rose to almost full tolerance at the end of the experiment. We interpret these results as
indicating that the stable levels of ampicillin- and ciproﬂoxacin-tolerant cells after
inoculation and throughout early exponential growth represent dormant cells that
have been carried over from the overnight cultures and not a steady state of persister
formation and resuscitation. This interpretation is also in line with the direct correlation
of the inoculum with the fraction of antibiotic-tolerant cells that we had observed
before (Fig. 1B and C).
Persister assays with ciproﬂoxacin in E. coli K-12 are affected by induction of
resident prophages. Beyond these issues related to the growth conditions of bacteria
studied in persistence assays, a recent publication by members of the Brynildsen
laboratory on Staphylococcus aureus persister formation alerted us that the presence of
resident prophages might affect measurements of persister frequencies under some
conditions (26). In short, those authors showed that ciproﬂoxacin treatment at the
commonly used concentrations of 0.5 to 1 g/ml—more than an order of magnitude
above the MIC and sufﬁcient to kill all regular cells—eliminates a substantial fraction of
persisters and that the effect is not due to the direct action of the antibiotic but is
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instead due to the secondary activation of prophages. This effect could be overcome
at very high concentrations of ciproﬂoxacin that cause a strong inhibition of cellular
DNA processing and thus impair prophage development (26). Given that DNA damage
is generally known to be a strong inducer of temperate prophages, including some of
the cryptic prophages in the E. coli K-12 MG1655 chromosome (27, 28), we suspected
that a similar effect described by Sandvik et al. (26) may also affect the persister results
reported for E. coli. We therefore compared the E. coli K-12 wild-type strain to a
previously published mutant devoid of all nine cryptic prophages for tolerance to
different concentrations of ciproﬂoxacin in a classical single-growth-time-point per-
sister assay (Fig. 3). Similarly to the results reported for S. aureus, the E. coli K-12
wild-type strain showed a minimum of survival at commonly used intermediate con-
centrations of ciproﬂoxacin (0.5 to 1 g/ml) and displayed greatly increased survival at
higher concentrations (Fig. 3A). This effect was abolished in the mutant lacking the
cryptic prophages (Fig. 3B). Studying the gap between survival of 1 g/ml ciproﬂoxacin
treatment and survival of 10 g/ml ciproﬂoxacin treatment over time, we found that
the difference was considerable (around 1 log) throughout all growth phases but was
most pronounced during exponential growth (Fig. 3C and D). To avoid artifacts from
the induction of cryptic prophages, we therefore adopted 10 g/ml as the standard
concentration of ciproﬂoxacin for antibiotic killing assays.
E. coli 1-10TA bacteria carry a defective lambda prophage. The major effect of
cryptic prophages on the detection of ciproﬂoxacin-tolerant persisters caught our
attention, because a previous analysis of the genome sequence of our E. coli K-12
MG1655 10TA strain by the members of Kim Lewis’s laboratory had revealed an
accumulation of nucleotide polymorphisms in the cryptic prophages (5). The 10TA
strain had been created by the sequential deletion of 10 mRNA endonuclease toxin TA
FIG 2 Persister formation of E. coli K-12 MG1655 in M9 medium. (A) Scheme illustrating how the dynamics of persister formation were
determined. (B) Bacterial growth and the dynamics of antibiotic-tolerant cells were determined for cultures of E. coli K-12 MG1655 in M9
minimal medium as described for the experiment whose results are shown in Fig. 1 after inoculation at a dilution of 1:100 from a dense
overnight culture. (C) Fraction of antibiotic-tolerant cells for each data point shown in panel B. We generated biphasic kill curves to verify
that the antibiotic-tolerant cells present during exponential growth (3 h after inoculation) represented persisters (Fig. S2). Data points
represent means of results from at least three independent experiments, and error bars indicate standard deviations.
Prophages and Culture Conditions Affect Persister Assays ®
November/December 2017 Volume 8 Issue 6 e01964-17 mbio.asm.org 5
 
m
bio.asm
.org
 o
n
 January 15, 2018 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
FIG 3 Induction of cryptic prophages distorts persister measurements of E. coli K-12. Exponentially
growing cultures of E. coli K-12 strain BW25113 (A) and its derivative lacking all nine cryptic prophages
(B; 9CP) created by Wang et al. (28) were treated with different concentrations of ciproﬂoxacin in M9
medium, and the level of surviving persister cells was determined. Note that the level of survivors for the
wild-type strain increased at high ciproﬂoxacin concentrations, while no such effect can be observed in
the Δ9CP mutant. The latter strain generally exhibits a lower level of persister formation than its ancestor,
possibly due to the roles of prophage-encoded factors in persistence and general stress tolerance (28).
(Continued on next page)
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modules and was described to display the strong defect in bacterial persistence that
was a cornerstone of our previous work (8, 9). We recently discovered that the
published variant of E. coli 10TA carried a lambda prophage. The infection was easily
cured genetically (see Materials and Methods), and the resulting strain, E. coli K-12
MG1655 10TA attB(), did not show any difference from parental E. coli K-12 MG1655
10TA () in persister levels (see below). However, a general concern regarding
prophage-mediated effects on persistence and the sustained debate over the results of
our previous work prompted us to sequence the genome of E. coli K-12 MG1655 10TA
attB(). Additionally, we sequenced two ancestors of mutant 10TA, namely, strains
5TA and 8TA, in which ﬁve and eight mRNA endonuclease toxin TA modules had
been deleted, respectively (9). Notably, the 5TAmutant had been the ﬁrst strain in the
series of sequential TA module deletions of our previous work that was found to exhibit
a defect in persister formation (9).
Surprisingly, the genome sequences showed that mutants 5TA and 8TA carried a
lambda prophage at the attB site in the gal-bio region of the E. coli chromosome
(Fig. 4A). We therefore tested the most important strains of our previous studies for
lambda infection by PCR and found that every TA module deletion strain of the series
leading to mutant 10TA, as well as the relA spoT mutant [deﬁcient in (p)ppGpp
FIG 3 Legend (Continued)
(C) Bacterial growth and the dynamics of antibiotic-tolerant cells were determined for cultures of E. coli
K-12 MG1655 in M9 minimal medium as described for Fig. 2B, and the results of treatment with 1 g/ml
and 10 g/ml ciproﬂoxacin were compared. (D) Data representing the fraction of antibiotic-tolerant cells
at each time point are shown. Data points represent means of results from at least three independent
experiments, and error bars indicate standard deviations.
FIG 4 Lambda and 80 infection of strains from our previous studies. (A) The insertion of a lambda prophage (blue gene arrows) in the E. coli
K-12 chromosome (gray gene arrows) is shown together with coverage of the prophage insertion in the genomes of the 5TA and 8TA mutants
(gray bar below). The 13-kilobase deletion comprising cI, cII, and cIII repressors spans a sequence from the gam nuclease inhibitor gene to the
endolysin gene R. (B) Diagnostic PCR analyses of the two junctions between the lambda prophage and the gal-bio region of the E. coli
chromosome were performed to determine the extent of lambda infection in important strains from our previous studies (8, 9). (C) Insertion of
a 80 prophage (orange gene arrows) in the E. coli K-12 chromosome (gray gene arrows) in the genomes of 5TA, 8TA, and 10TA attB()
mutants. (D) Diagnostic PCR analyses of the two junctions between the 80 prophage and the yciI locus in the E. coli K-12 chromosome were
performed to determine the prevalence of 80 infections among important strains from our previous work (8, 9).
Prophages and Culture Conditions Affect Persister Assays ®
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signaling], was a lambda lysogen (Fig. 4B). Interestingly, the genome sequences of
mutants 5TA and 8TA revealed a deletion of ca. 13 kb inside the lambda prophage
around the major repressor genes cI, cII, and cIII and major promoters, suggesting that
the prophage is defective and largely inactive (Fig. 4A).
Widespread infection with 80 in strains used to support the model. Beyond a
defective lambda prophage in mutants 5TA and 8TA, we discovered that each of the
three sequenced strains of our TA module deletion series carried a 80 prophage at its
attP integration site in the yciI gene (Fig. 4C). We therefore performed diagnostic PCRs
on the junctions of 80 integration in all strains that were crucial for the main results
of our previous articles (8, 9). These experiments revealed 80 infections in the
5TA-10TA, relA spoT, and ppkx (polyphosphate metabolism) mutants (Fig. 4D).
In parallel to studying the 80 infections, we investigated whether the lambda
prophages in our strains all carried the 13-kb deletion revealed for mutants 5TA and
8TA by testing their susceptibility to the lambda cIb221 mutant encoding an inactive
cI repressor gene. The lambda cIb221 mutant is obligately lytic unless cI is provided in
trans, e.g., by a lambda prophage. Surprisingly, the 10TA attB() strain was immune
to lambda cIb221 infection although it had been cured of the lambda prophage, but all
TA module deletion strains before and including mutant 8TA were sensitive (Fig. 5A).
These results show that the lambda prophage had already been inactivated in mutant
1TA and may already have been present in the ancestral E. coli K-12 MG1655 wild-type
stock. The surprising immunity of mutants 9TA and 10TA to lambda cIb221 suggested
that these strains must encode a source of lambda cI outside the defective prophage
that lacks cI. Consistently, a deeper analysis of the 10TA attB() genome sequence
identiﬁed a 12-kb piece of lambda centered around the cI gene (Fig. 5B). Interestingly,
the ﬂanking regions of this lambda segment were 80 sequences and not part of the
E. coli K-12 MG1655 genome, indicating that these strains had been infected with a
80/lambda hybrid on top of the 80 wild-type phage. Given that the genetic
architectures of these two phages are very similar, hybrid phages are often viable and
had been used as tools to study different features of phage biology in earlier times (29).
A comparison of the 10TA attB() genome sequence with those of the published
80/lambda hybrids revealed that the hybrid phage in our strains is known as
80h(80)imm(), a phage that produces 80 particles but carries a lambda immunity
region (Fig. 5B) (29).
Unlike the lambda prophage, the 80 prophages seemed complete and thus likely
active. This observation caught our attention, because 80 is known as a highly
infectious laboratory contaminant (30, 31) and because we had widely distributed the
strains of our TA module deletion series to other research groups. We therefore
performed plaque assays on regular overnight cultures of various strains to determine
the infectivity of 80 present in our lysogens. As expected, culture supernatants of all
strains that had been found to carry a 80 prophage by PCR (Fig. 4C) formed plaques
on a lawn of E. coli K-12 wild-type cells but did not do so on cells of a fhuA mutant that
lacks the 80 receptor (Fig. 5C).
Lysogenization with 80 reduces persisters to levels similar to those seen with
TA module deletions in mutant 10TA. We were particularly concerned by the 80
lysogenization because this prophage is known to be easily induced by DNA damage
(30) and because this property might reduce the number of survivors of treatment with
ciproﬂoxacin, the major antibiotic that was used in our previous study (8). We therefore
lysogenized the E. coli K-12 MG1655 wild-type strain using 80 particles from the
supernatant of mutant 10TA attB() and assayed persister formation of this strain in
direct comparison to the levels seen with the parental wild-type strain and the 10TA
mutant (Fig. 5D). When the experiment was performed as a single-growth-time-point
assay in LB medium as in our previous work, we readily reproduced the signiﬁcant drop
of ampicillin and ciproﬂoxacin survival that had been reported for the 10TA mutants
compared to the E. coli K-12 wild-type strain (8, 9). Lysogenization of E. coli K-12 with
80 had no effect on ampicillin tolerance but caused the same drop of ciproﬂoxacin
Harms et al. ®
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survival that had been a leading phenotype of mutant 10TA and other infected strains
in our previous studies (Fig. 5D) (8, 9). Furthermore, the difference between the E. coli
K-12 wild-type strain and the 10TA mutants in ampicillin tolerance disappeared when
the experiment was performed in M9 minimal medium (Fig. 5E), as had already been
reported by Shan et al. (5). Taken together, these results directly questioned whether
there was any 80-independent difference between the E. coli K-12 wild-type strain and
the 10TA mutants in persister formation or survival. In M9 minimal medium, interest-
ingly, the 10TA strains displayed clearly reduced survival of ciproﬂoxacin treatment
compared to the results seen with the 80 lysogen, possibly due to some of the
additional mutations present in the 10TA genome revealed by Shan et al. (5) or due
to the additional presence of 80h(80)imm(). Unlike what we had observed for the
cryptic prophages of E. coli K-12 (Fig. 3), an increase in the ciproﬂoxacin concentration
from the commonly used concentration of 1 g/ml to 10 g/ml did not reduce the
drop in survival caused by lysogenization with 80 (Fig. 5D and E). It seems likely that
FIG 5 Lambda immunity and active 80 prophages and their effect on persistence. (A) The sensitivity of different E. coli strains to the lambda cIb221 mutant
was determined by streaking across lines of phage stock on agar plates. Red, no growth/sensitive; green, growth/immune. (B) Illustration of neighboring 80
and 80h(80)imm() integration in the chromosome of E. coli 10TA as deduced from the genome sequence. The E. coli chromosome backbone is shown in gray;
genes of 80 and 80h(80)imm() are shown in orange and dark orange, respectively; and the lambda region of the 80h(80)imm() mutant is highlighted in blue.
Note that the genome sequence does not unambiguously tell which of the prophages is upstream and which is downstream in the integration site. (C) A plaque
assay with culture supernatants and control phage stocks was performed to determine the infectivity of prophage carriers. wt, wild type. (D and E) Exponentially
growing E. coli K-12 MG1655 and different mutant derivatives/lysogens were challenged with ampicillin, ciproﬂoxacin, or gentamicin in LB medium (D) or M9
medium (E), and the fractions of surviving persisters were calculated. Data points represent averages of results from three independent experiments, and error
bars represent standard deviations.
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this difference in behavior was due to the high sensitivity of 80 induction to even
slight DNA damage that may remain after the end of ciproﬂoxacin treatment and
persister resuscitation (30), while the induction of cryptic prophages of E. coli K-12
requires very strong DNA damage (28). No differences between the 10TA mutants
with and without the defective lambda prophage in the attB site or between any strains
regarding gentamicin tolerance could be detected (Fig. 5D and E).
ppGpp, Lon, and polyphosphate in E. coli K-12 persister formation. The ability
of 80 carriage to cause the same drop in persistence that we had previously attributed
to the deletion of ten TA modules was worrying, because we had found this prophage
in nearly all mutant strains that supported the model of persister formation proposed
by our previous work (8). We therefore constructed new, uninfected versions of all
mutants that had been found to be 80 lysogens and assayed the dynamics of persister
formation of these strains in order to determine whether the model still held (see
Fig. 6A for a summary of the model and Materials and Methods for strain construction).
This model is based on the second messenger (p)ppGpp that plays important roles
in persister formation of diverse organisms (2, 32). Consistently, we had previously
reported severe defects in the formation or survival of ampicillin- and ciproﬂoxacin-
tolerant persisters for mutants deﬁcient in (p)ppGpp synthesis (relA spoT strains) (8).
Subsequently, there had been some debate in the ﬁeld whether pleiotropic phenotypes
of these mutants such as slow growth, long lag times, and reduced stationary-phase
viability might have affected our results (5, 16). We therefore compared the dynamics
of antibiotic tolerance in cultures of a relA spoT mutant of E. coli K-12 MG1655 to those
of the parental wild-type strain in a variant of our M9 medium that had been
supplemented with a mixture of amino acids to support growth at roughly the same
rate for the two strains (see Materials and Methods as well as the report by Potrykus et
al. [33]). Under these conditions, we observed a considerable defect of the relA spoT
mutant in tolerance to ciproﬂoxacin and gentamicin throughout all growth phases,
though the overall shape of the curves following the levels of tolerant cells over time
was only poorly affected (Fig. 6B and C). The relA spoT mutant also seemed to display
a defect in tolerance to ampicillin during exponential growth, though the very different
ﬁnal cell densities and the early onset of full ampicillin tolerance upon cessation of
growth by the relA spoT mutant made it difﬁcult to judge this phenotype (Fig. 6B
and C).
Downstream of (p)ppGpp, the model proposed by Maisonneuve et al. (8) comprises
the production of polyphosphate by polyphosphate kinase (PPK) and degradation by
exopolyphosphatase (PPX) (both lacking in the Δppkx deletion mutant that produces
little polyphosphate), the polyphosphate-dependent activation of Lon (impaired in a
lon deletion mutant), and the degradation of TA module antitoxins by Lon to activate
toxins and induce persistence (impaired in a 10TA knockout mutant; Fig. 6A). Notably,
the only one of these mutant strains of our previous studies that showed a defect in
bacterial persistence but that had not been infected with 80 was the lon::tet strain
(Fig. 4D) (8, 9). However, the use of lon single mutants is prone to artifacts in persister
assays due to the activation of SulA, an inhibitor of cell division, in response to DNA
damage which is essentially irreversible in the absence of Lon, which degrades SulA (27,
34). We therefore created a sulA lon double mutant similar to the one that was used by
Theodore et al. (34) in order to exclude these artifacts. This mutant showed a defect in
the formation or survival of ciproﬂoxacin-tolerant persisters during exponential growth
and also exhibited a markedly slower increase in ampicillin tolerance during stationary
phase (Fig. 7). Conversely, the ppkx mutant showed a drop in ciproﬂoxacin tolerance
only in stationary phase and was, beyond a slightly shifted curve likely caused by its
slower growth, not affected in ampicillin tolerance (Fig. 7). We therefore conclude that
our results conﬁrm roles of (p)ppGpp as well as the Lon protease in the formation of
persister cells by E. coli K-12, but these data cannot verify whether or not they are part
of the same pathway as suggested previously. Furthermore, we failed to detect any
phenotype of a newly constructed 10TA strain (called strain 10=TA) without
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prophages in tolerance to any of the tested antibiotics at any time point compared to
the parental wild-type strain (Fig. 7). It appears therefore that unnoticed lysogenization
with 80 has been the reason for all of the persister phenotypes that we detected with
the initial 10TA strain.
DISCUSSION
Persister phenotypes as an “inside job” of 80. In this study, we showed that
important aspects of our previously published model of persister formation were based
FIG 6 The model of (p)ppGpp-dependent persister formation through TA modules. (A) The illustration
(adapted from Germain et al. [54]) shows our previously published model of persister formation initiated
by stochastic bursts of (p)ppGpp that induce the production of polyphosphate which stimulates Lon to
degrade TA module antitoxins. Consequently, the activation of mRNA interferase toxins would induce
bacterial persistence (8). (B and C) In order to verify the most upstream element of the model, we created
a new (p)ppGpp-deﬁcient mutant of E. coli K-12 MG1655 (relA spoT) and assayed the dynamics of
antibiotic tolerance seen in the experiment described for Fig. 2 with minor modiﬁcations (see Materials
and Methods).
Prophages and Culture Conditions Affect Persister Assays ®
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on the misinterpretation of experimental results caused by the unnoticed lysogeniza-
tion of many of our strains with bacteriophage 80. Consequently, defects in persister
formation that we had previously attributed to different genetic mutations were
instead a consequence of 80 prophages residing in the chromosomes of these strains.
Others had previously questioned our model of persister formation based on a
number of different considerations. Most importantly, some studies did not observe
phenotypes of strains deﬁcient in important components of our model in single-
growth-time-point persister assays under their conditions. For example, Shan et al. (5)
did not detect a defect of lon sulA and ppkx strains in persister formation or survival
upon treatment with ampicillin and ciproﬂoxacin. Also, while the role of (p)ppGpp as an
important controller of persister formation is generally well established (2, 32), recent
studies suggested that the link between (p)ppGpp signaling and the activation of TA
modules needs to be reinvestigated. As an example, an article by Ramisetty et al. (18)
and an associated commentary by Van Melderen and Wood (13) raised the point that
some of the antitoxins of the ten TA modules implicated in our model may not be
targets of the Lon protease. Furthermore, they used the yefM-yoeB TA module as a
model to study the link between (p)ppGpp and TA module activation and reported that
polyphosphate was, in their hands, not required for yefM-yoeB activation after experi-
mental induction of (p)ppGpp signaling or Lon overexpression (18). We agree that the
role of polyphosphate requires further investigation, and, with the reﬁned methodol-
FIG 7 Protease Lon, but not mRNA endonuclease TA modules, contributes to persistence. We studied the dynamics of antibiotic tolerance for
cultures of newly constructed E. coli K-12 Δppkx, sulA::FRT Δlon, and 10=TA mutants in comparison to the parental wild type similarly to the
experiment whose results are shown in Fig. 2. Changes in overall and antibiotic-tolerant CFU per milliliter are plotted in panel A, and the fractions
of antibiotic-tolerant cells are plotted in panel B. While the sulA::FRT Δlon mutant showed a clear defect in persister formation or survival during
exponential growth (around 3 h after inoculation; see also Fig. S2), the parental sulA::FRT strain had no such phenotype (Fig. S3), conﬁrming that
the defect was due to the lack of Lon.
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ogy of our current study, we could not conﬁrm a role of this molecule in the formation
and survival of persister cells during exponential growth of E. coli K-12 (Fig. 7). For Lon,
others had previously argued that our failure to use a sulA lon double mutant might be
the reason that we detected persister phenotypes of Lon-deﬁcient strains that they
were unable to reproduce (5, 34). In our hands, the sulA lon double mutant showed a
clear 1-log reduction in the levels of ciproﬂoxacin-tolerant persisters during exponential
growth (Fig. 7), supporting our previous observations (8) and suggesting that the
degradation of Lon targets—either speciﬁc targets like antitoxins or simply unfolded
proteins—is important for persister formation or survival. Future studies should there-
fore further investigate the links between (p)ppGpp, protease Lon, and bacterial
persistence.
Beyond Lon and polyphosphate, considerable criticism revolved around the issue of
whether our 10TA strain was a useful tool to study the link between TA modules and
bacterial persistence. Others have reported various signs of slightly decreased viability
of the original 10TA strain, such as a minor drop in the MIC of several antibiotics, that
they traced back to polar effects of our TA module deletions or of additional mutations
acquired during the long series of recombineering steps (13, 18). Notably, changes in
MIC should not affect persistence per se (19), but it is entirely possible that these
phenotypes of the 10TA strain are caused by the 80 prophage that indeed increases
the sensitivity of E. coli K-12 to, e.g., DNA-damaging agents (30). Beyond ampicillin and
ciproﬂoxacin, we systematically included in this study the aminoglycoside gentamicin
in our antibiotic killing assays but did not detect any relevant differences in tolerance
to this antibiotic (apart from the results seen with the relA spoT mutant; Fig. 6). We
chose gentamicin as a control because others showed previously that persister cells
formed through the activity of mRNA endonuclease toxins should not be appreciably
tolerant to aminoglycoside antibiotics, since these toxins fail to fully shut down
translation and thus cannot prevent its poisoning by aminoglycoside drugs (35).
Notably, other mechanisms of persister formation such as the activation of different TA
modules (with small peptide toxins that abrogate the proton motive force) readily
confer tolerance to aminoglycosides (4).
Current evidence for a role of TA modules in persister formation. Though we
conclude that no evidence remains to support a role of the set of 10 mRNA endonu-
clease toxin TA modules in persister formation of E. coli K-12 in unstressed cells, we
continue to favor the hypothesis that at least some of these elusive genetic elements
act as phenotypic switches into dormancy, a view largely shared by others in the ﬁeld
(1, 2, 32, 36). Others have conﬁrmed important roles of different sets of TA modules in
persister formation of E. coli K-12 and related organisms such as uropathogenic E. coli
and Salmonella (3, 4, 17, 37). With respect to mRNA endonuclease TA modules,
phenotypes of even single TA module deletions under speciﬁc conditions have repeat-
edly been described in the ﬁeld; e.g., yafQ mutants of E. coli K-12 were found to be
speciﬁcally defective in persister formation inside bacterial bioﬁlms (38–40). Consis-
tently, it is becoming clearer and clearer that different TA modules in E. coli and beyond
may respond to different forms of upstream signaling (5, 41). We therefore argue that
the role of mRNA endonuclease TA modules in persister formation of E. coli K-12 and
a possible link to Lon deserve further investigation, even though our previously
reported phenotypes with TA modules do not hold true in the absence of 80.
Raising awareness of bacteriophage 80. Beyond the confusion created by our
erroneous interpretation of results obtained with 80-infected strains, we are worried
that we have sent these strains to many research groups. Though it has been one of the
favorite model phages in the early days of molecular biology (29), 80 is now notorious
as a laboratory contaminant. This bacteriophage combines “opportunistic induction”
(i.e., a high frequency of spontaneous lytic development) with “stealth infectivity, i.e.,
the comparably low infectivity of particles at 37°C and a relatively high preference for
lysogeny (30, 31). Contamination of strains with 80 can therefore go unnoticed for a
long time—E. coli K-12 5TA, the ﬁrst strain of the TA module deletion series carrying
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80, was ﬁrst published by Christensen et al. in 2004 (42). However, elusive phenotypes
such as a reduced efﬁciency of P1vir transductions can represent strong hints of 80
contaminations (30). Due to the inability of 80 to adsorb to stationary-phase cells,
overnight cultures of lysogens regularly build up very high titers without any apparent
sign of lysis (see also Fig. 5C), facilitating contamination. Additionally, 80 readily
spreads through P1vir transductions from infected strains (30). We can therefore only
suggest that our colleagues regard the danger of 80 contamination seriously and use
simple PCR tests such as the one represented by Fig. 4B to unravel if enigmatic
phenotypes may be caused by 80 infection. Of note, we have tested a random sample
of (published) E. coli strains that we had obtained from different laboratories at different
times and found several independent cases of 80 infection.
A reﬁned methodology to study bacterial persister formation. Beyond the
effects of 80, we showed that the use of intermediate concentrations of ﬂuoroquino-
lones (such 0.5 to 1 g/ml of ciproﬂoxacin) for E. coli persister assays is inappropriate,
because—in full congruency with the results of Sandvik et al. (26) for S. aureus—
ca. 1 log of bacterial killing at these concentrations is caused not directly by the
antibiotic but rather by the induction of resident prophages (Fig. 2). It therefore cannot
be determined with certainty if phenotypes observed with experimental interventions
or mutant strains are caused by differences in persister formation/survival or by effects
on prophage induction. Future studies should therefore use higher concentrations of
these antibiotics that inhibit prophage development, e.g., 10 g/ml of ciproﬂoxacin.
Our results further suggest that protocols commonly used to study “exponential-
phase” persister formation are greatly affected by the carryover of dormant cells and/or
molecules from overnight cultures (Fig. 1 and 2). This effect may mask actual
exponential-phase persister formation until the absolute level of newly formed persister
cells overcomes the level of inoculated dormant cells. It seems likely to us that this
phenomenon may have contributed to the inconsistencies of results published by
different laboratories, because persister assays performed with antibiotic treatment at
the same cell densities can give very different results depending on the amount of the
initial inoculum (Fig. 1). Future studies should consider this effect in designing exper-
iments and, if possible, should, e.g., include controls of bacteria that are in a state of
balanced growth, i.e., that have completed an amount of divisions since their inocu-
lation from stationary phase sufﬁcient for effects of carryover to be excluded (43).
In this study, we regularly used a very laborious setup of antibiotic killing assays that
followed the levels of antibiotic-tolerant CFU per milliliter throughout the different
growth phases of E. coli (see Fig. 2A). Similar experiments have already been performed
previously, e.g., in the seminal study by Keren et al. (44). Though a number of
experimental parameters differed between that study and our current work, there is
clear agreement that the levels of -lactam and ﬂuoroquinolone tolerance are similar
in early growth phases after inoculation and later increase strongly until they reach (for
-lactams) full tolerance when the bacteria cease growth (Fig. 1 and 2; compare the
results reported by Keren et al. [44]). It seems likely that the stable level of tolerant cells
after inoculation may reﬂect a long lag phase of dormant cells carried over from
stationary phase, and others have indeed found growth lag to be the most important
aspect of antibiotic tolerance for bacteria that are inoculated from stationary phase
directly into fresh medium with antibiotics (45). It has therefore already been reason-
ably argued in the ﬁeld that future studies should follow sufﬁciently elaborate meth-
odologies in order to unravel the complexity of various antibiotic-tolerant subpopula-
tions in bacterial cultures (16, 19, 21). We have also observed very interesting and
highly divergent dynamics of E. coli K-12 tolerance to different antibiotics and in
different media (Fig. 1 and 2) that could not be explored in this study. However, it
seems a promising ﬁeld for future studies to compare the appearance and disappear-
ance of tolerant cells for different antibiotics and for trying to uncover which external
and intrinsic factors control antibiotic tolerance.
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MATERIALS AND METHODS
Bacterial strains and their construction. E. coli mutants were routinely constructed using recom-
bineering with expression of the lambda red recombination genes from plasmid pWRG99 (46, 47). Clean
deletions were constructed in a two-step procedure that ﬁrst replaced the target gene(s) with the
double-selectable cassette of template plasmid pWRG100, conferring chloramphenicol resistance for
positive selection and carrying an I-SceI site for negative selection upon expression of the I-SceI
endonuclease from pWRG99 (47). The double-selectable cassette was then removed through recom-
bineering with a pair of annealed 80mer oligonucleotides spanning the desired deletion site with 40-bp
homologies on each side. All bacterial strains used in this study are listed in Table S1 in the supplemental
material. The nucleotide sequences of all oligonucleotide primers are listed in Table S2.
E. coli K-12 MG1655 relA::FRT spoT::cat(207), also known as PDC47, was constructed in two steps. The
relA gene was deleted by P1vir transduction of the relA::kanR allele of the corresponding deletion strain
of the Keio collection and subsequent recombination of the ﬂanking FLP recombination target (FRT) sites
using pCP20 (46, 48). In a second step, the spoT::cat(207) allele was transduced from E. coli CF1693 (49).
E. coli K-12 MG1655 Δppkx, also known as AHK062, was constructed by two-step recombineering as
described with ampliﬁcation of the double-selectable cassette using prAH1469/prAH1470 and 80mer
oligonucleotides prAH1491/prAH1492.
E. coli K-12 MG1655 sulA::FRT Δlon, also known as AHK173, was constructed from the E. coli K-12
MG1655 sulA::kanR strain described by Maisonneuve et al. (8) in two steps. We ﬁrst removed the
kanamycin resistance cassette by recombination of the ﬂanking FRT sites using pCP20 (46) and then
deleted lon by two-step recombineering with a double-selectable cassette ampliﬁed using prAH1465/
prAH1466 followed by recombineering with 80mer oligonucleotides prAH1493/prAH1494.
E. coli K-12 MG1655 10=TA, i.e., E. coli K-12 MG1655 ΔhicAB::FRT ΔmqsR::FRT ΔyafO::FRT ΔyhaV::FRT
ΔhigB::FRT ΔyhaV-yoeB ΔdinJ-yafQ ΔrelBE ΔchpBS ΔmazF (also known as AHK250), was constructed by
sequential deletion of the remaining 5 TA modules/TA module toxins on the basis of E. coli K-12 MG1655
5=TA strain described by Maisonneuve et al. (9) that has the genotype ΔhicAB::FRT ΔmqsR::FRT ΔyafO::
FRT ΔyhaV::FRT ΔhigB::FRT. That strain had been created by deleting ﬁve mRNA interferase toxins in
reverse order with respect to the TA module deletions of mutant 10TA. Of note, mutant 5=TA (unlike
mutant 10TA or mutant 5TA) does not carry a lambda or 80 prophage and does not show any
difference from the parental wild-type strain in bacterial persister formation (see Fig. S4 in the supple-
mental material). The initial study by Maisonneuve et al. (9) had described a substantial defect of the
5=TA strain in bacterial persistence, but we were unable to reproduce this phenotype (Fig. S4),
suggesting that the original work might have erroneously mixed up bacterial strains or inadvertently
infected the clone used for experimentation with 80. We deleted the yefM-yoeB locus in the 5=TA strain
using a double-selectable cassette ampliﬁed with prAH1633/prAH1652 and the 80mer oligonucleotide
pair prAH1653/prAH1654. The dinJ-yafQ TA module was deleted with a double-selectable cassette
ampliﬁed using prAH1627/prAH1649 and subsequent recombineering of 80mer oligonucleotides
prAH1659/prAH1660. Subsequently, the relBE module was deleted using a double-selectable cassette
ampliﬁed with primers prAH1631/prAH1651 and the 80mer oligonucleotides prAH1655/prAH1656. We
deleted the chpBS locus with a double-selectable cassette ampliﬁed using prAH1648/prAH1626 followed
by recombineering of 80mer oligonucleotides prAH1661/prAH1662. Finally, the mazF toxin gene was
deleted using a double-selectable cassette ampliﬁed with prAH1629/prAH1650 and the 80mer oligonu-
cleotides prAH1657/prAH1658. We conﬁrmed the successful introduction of all deletions in the 10=TA
strain and also the parental 5=TA strain using diagnostic PCRs over the TA loci.
E. coli K-12 MG1655 80() was generated by lysogenization of the parental wild-type strain with
80 of strain 10TA attB(). In short, culture supernatant of E. coli 10TA attB() was prepared as
described for the plaque assays outlined below and 100 l was added to a culture of E. coli K-12 MG1655
at an optical density at 600 nm (OD600) of ca. 0.2. The culture was agitated at 30°C until lysis occurred,
and survivors were plated on LB agar plates. After overnight incubation at 37°C, single colonies were
tested for a K-12 MG1655 wild-type chromosomal background (by PCR on TA module loci) and carriage
of only wild-type 80 (by sensitivity to lambda cIb221).
Curing of the lambda prophage from E. coli K-12 10TA. The original E. coli 10TA strain
described by Maisonneuve et al. (9) was cured of its lambda prophage via a two-step P1vir transduction
procedure. In short, the lambda prophage was ﬁrst replaced with a temperature-sensitive RED variant,
and this prophage was subsequently cured by P1vir transduction of a native gal-bio region with an
unoccupied attB integration site from the E. coli K-12 MG1655 wild-type strain.
Strain HME71 described by Sawitzke et al. (50) carries a temperature-sensitive RED prophage and
was cured for its Δ(srlA-recA)301::Tn10 insertion by P1vir transduction of the native locus from the E. coli
K-12 MG1655 wild-type strain in order to restore tetracycline sensitivity by removal of the resistance
marker carried on the Tn10 transposon. Transduction of the wild-type locus was selected as sorbitol
prototrophy (Srl) and veriﬁed by screening for a Rec phenotype and tetracycline sensitivity. Subse-
quently, the resulting strain (MAS889) was transduced back to tetracycline resistance with a P1vir lysate
raised on strain MAS242 that carries a mini-Tn10 inserted close to galE near the attB lambda attachment
site, thus establishing a tetracycline resistance marker that is genetically linked to RED. Transductant
colonies were screened for temperature sensitivity (i.e., the presence of RED). A P1vir lysate of the
resulting strain, MAS902, was used to transduce tetracycline resistance into E. coli 10TA in order to
replace the resident lambda prophage with RED. Successful replacement was veriﬁed by screening for
temperature sensitivity. Subsequently, the wild-type gal-bio region with an unoccupied attB site was
transduced from E. coli K-12 MG155 by selection for galactose and biotin prototrophy (Gal Bio) and
loss of temperature sensitivity, creating strain E. coli 10TA attB(). Loss of tetracycline resistance was
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veriﬁed and successful curing of lambda prophages was conﬁrmed by the detection of an unoccupied
attB site using overspanning PCR with primer pair prMASgal/prMASbio of Baek et al. (51). Different efforts
to cure 80 infections from lysogens have remained unsuccessful, as reported earlier by others (30).
Preparation of culture media. Luria-Bertani (LB) broth was prepared by dissolving 10 g of tryptone
(catalog no. LP0042; Oxoid), 5 g of yeast extract (catalog no. LP0021; Oxoid), and 10 g of sodium chloride
(catalog no. 27810.364; VWR Chemicals) per liter of Milli-Q H2O and sterilized by the use of an autoclave.
M9 medium was prepared as “M9 minimal medium (standard)” according to the Cold Spring Harbor
protocols (52) with modiﬁcations in the form of 1 M9 salts (stock solution prepared from 5 M9 salts
[catalog no. M6030; Sigma-Aldrich]), supplemented with 50 l of a 10 mg/ml FeSO4 solution (catalog no.
F8048; Sigma), 0.4% (wt/vol) Bacto Casamino Acids (catalog no. 223020; BD Biosciences) (from 20%
[wt/vol] sterile-ﬁltered stock), 0.4% (wt/vol) D-glucose (catalog no. 101176K; VWR Chemicals) (from 40%
[wt/vol] stock), 2 mM MgSO4 (catalog no. 25.165.292; VWR Chemicals), 1 g/ml thiamine (catalog no.
T1270; Sigma), and 100 M CaCl2 (catalog no. 26.764.298; VWR Chemicals). For (p)ppGpp-deﬁcient strain
E. coli K-12 MG1655 relA::FRT spoT::cat(207), Casamino Acids in the M9 medium were replaced with
400 g/ml of L-serine and 40 g/ml of all other amino acids (Sigma) (all 98% or 98% purity) to
support reasonable growth of this delicate strain as described by Potrykus et al. (33).
Persister assays. The presence of persister cells in bacterial cultures is usually detected using
biphasic kill curves in which the addition of a bactericidal antibiotic is followed ﬁrst by rapid killing of
regular cells and then by a second, slower phase in which persister cells are killed (1, 2). Persister cells
can then be quantiﬁed by comparing the levels of survivors obtained with, e.g., different mutant strains
after a given time of antibiotic treatment. Experimental procedures similar to the one used here had also
been described in our previous work and in reports of numerous studies by others in the ﬁeld (5, 8, 9,
11). These studies showed that antibiotic treatment in LB medium and different minimal media for
exponentially growing bacteria of ca. 1 to 5 108 CFU/ml results in biphasic killing with merely persisters
surviving after 5 h. Similarly, we demonstrated biphasic killing under these conditions for the M9 minimal
medium that we used throughout this work (Fig. S2).
Overnight cultures were inoculated from single colonies into 3 ml of LB or M9 medium and grown
for ca. 16 h in plastic culture tubes (catalog no. 62.515.006; Sarstedt; the lid was taped at the 13-ml mark
with its lower end to ensure uniform aeration of replicates). For persister assays based on a single growth
time point as described in Fig. 1A, overnight cultures were diluted at 1:100 back into LB or M9 medium
in Erlenmeyer ﬂasks and agitated at 37°C in a water bath shaker until they were in the mid-exponential-
growth phase (ca. 1  108 CFU/ml to 5  108 CFU/ml; reached in our setup after ca. 2 to 2.5 h in LB
medium or 2.5 to 3 h in M9 medium). At that point, cultures were treated with lethal concentrations of
different antibiotics (100 g/ml ampicillin, 1 or 10 g/ml ciproﬂoxacin, or 7.5 g/ml gentamicin) for 5 h
in plastic culture tubes under conditions of rigorous agitation. In parallel, CFU counts per milliliter of the
cultures were determined by plating serial dilutions on LB agar plates. After antibiotic treatment,
bacterial pellets of 1.5-ml samples were washed once in 1 ml of sterile phosphate-buffered saline (PBS),
resuspended in 100 l of sterile PBS, and serially diluted in sterile PBS. Samples (10 l) were spotted on
LB agar plates to quantify antibiotic-tolerant survivors. Agar plates were incubated at 37°C for at least
24 h, and CFU counts per milliliter were determined from spots containing 10 to 100 bacterial colonies.
The fraction of persister cells was calculated as the ratio of the CFU counts per milliliter after and before
antibiotic treatment.
In order to study the dynamics of antibiotic-tolerant cells throughout the different growth phases of
E. coli (as outlined in Fig. 2A), we performed an experiment as described above but adjusted the time
between subculturing and antibiotic treatment from 0 h (i.e., direct inoculation into fresh medium
containing antibiotic) to 8 h. For experiments with the (p)ppGpp-deﬁcient strain E. coli K-12 MG1655
relA::FRT spoT::cat(207), the M9 growth medium was supplemented with an amino acid mixture instead
of Casamino Acids (see above) and the experiment was extended to 10 h. Though the relA spoT mutant
and E. coli K-12 wild-type strain have roughly the same growth rate in this medium, the ﬁnal CFU count
per milliliter of the (p)ppGpp-deﬁcient mutant is signiﬁcantly lower, which regularly results in experi-
mental artifacts due to the appearance of suppressor mutants during overnight cultures (33). We
therefore set up overnight cultures in LB medium (where this effect is much less pronounced) and
adjusted the inoculum of both the mutant and wild-type strains to ca. 106 CFU per milliliter in order to
account for the roughly 3-fold-higher CFU per milliliter of wild-type overnight cultures.
Genome sequencing and analysis. Genomic DNA of the E. coli K-12 MG1655 wild-type strain as well
as of its 5TA, 8TA, and 10TA attB() derivatives was isolated by phenol-chloroform extraction and
sequenced by GATC Biotech to a read length of 51 bp using an Illumina HiSeq 2500 sequencing platform.
Between 5 and 10 million paired end reads were obtained for each strain, resulting in an average 200-fold
sequencing depth. Sequencing reads were assembled using the Velvet assembler (53) in both de novo
and referenced modes, where the previously published genome of the E. coli K-12 MG1655 wild-type
strain (GenBank accession no. U00096) served as a template for the latter. Suspected prophage infection
was detected by assembling the raw contigs (around 20 per strain) to the published E. coli K-12 MG1655
genome sequence (GenBank accession no. U00096) and examining those not matching the reference by
BLAST searches.
Prophage detection by PCR. Prophage carriage was detected by PCR with oligonucleotide primer
pairs that ampliﬁed the two junctions between the E. coli K-12 chromosome and the prophage in the
gal-bio region (lambda) and at the yciI locus (80). Bacteriophage lambda was detected using primer
pairs prMASgal/prMASint (gal-int) and prMASb2/prMASbio (b2-bio) that have been used previously for
this purpose (51). Bacteriophage 80 was detected using primer pairs prAH1506/prAH1499 (kch-int) and
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prAH1500/prAH1521 (pinL-tonB). The nucleotide sequences of all oligonucleotide primers are listed in
Table S2.
Phage techniques. Our phage work followed standard techniques that had already been used by
others to study 80 infections (30, 31). Plaque assays were performed by spotting lytic phages or
correspondingly treated supernatants of E. coli cultures on LB plates overlaid with a top agar
containing E. coli strains as indicated. Lytic phage stocks were produced by diffusion of phage
particles into SMG buffer (0.1 M NaCl, 10 mM MgSO4, 0.05 M Tris [pH 7.5], 0.01% gelatin, Milli-Q H2O)
from top agar plates with conﬂuent plaques on E. coli K-12 MG1655. Supernatants of overnight
cultures of suspected 80 lysogens or control strains were separated from bacterial material by
centrifugation and then diluted 1:10 into SMG buffer containing 10% chloroform. For plaque assays,
LB agar plates in square format (12 cm by 12 cm) were overlaid with 7 ml of LB top agar (0.7%
agarose) containing 100 l of an overnight culture of the indicated E. coli strains. After the top agar
had solidiﬁed, 5 l of phage of supernatant stocks was spotted on the top. Plates were incubated
at 30°C (to enable efﬁcient plaque formation by 80 [30]) overnight until plaque formation was
visible. Sensitivity of bacterial strains to lambda cIb221 was assayed by evaluating the growth of
bacterial streaks that crossed lines of phage stock on LB agar plates supplemented with 20 mM
MgSO4 and 5 mM CaCl2. The ability of various strains to grow after contact with lambda cIb221 was
evaluated visually after overnight incubation of agar plates at 37°C.
Quantiﬁcation and statistical analysis. Experiments were usually analyzed by calculating means
and standard deviations of results from at least three biological replicates. Detailed information for each
experiment is provided in the ﬁgure legends.
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